Venmax Drugs and Pharmaceuticals Limited (BOM:531015)
25.00
+0.60 (2.46%)
At close: Mar 5, 2026
BOM:531015 Market Cap
BOM:531015 has a market cap or net worth of 185.06 million as of March 6, 2026. Its market cap has increased by 21.47% in one year.
Market Cap
185.06M
Enterprise Value
204.00M
Revenue
44.14M
Ranking
n/a
PE Ratio
16.83
Stock Price
25.00
Market Cap Chart
Since April 15, 2008, BOM:531015's market cap has increased from 32.40M to 185.06M, an increase of 471.20%. That is a compound annual growth rate of 10.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 185.06M | -7.37% |
| Dec 31, 2025 | 199.80M | 111.40% |
| Dec 31, 2024 | 94.51M | 357.87% |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 16, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Panchsheel Organics | 1.34B |
| Krebs Biochemicals & Industries | 1.12B |
| Resonance Specialties | 1.10B |
| Tyche Industries | 1.09B |
| Bacil Pharma | 673.30M |
| Vasundhara Rasayans | 381.38M |
| Crestchem | 267.63M |
| Ishita Drugs and Industries | 209.29M |